Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Quinlan Paul T. Officer active across 2 companies, notably CymaBay Therapeutics, Inc.. Cumulatively, 22 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €4.9m. History available since 15 May 2023. The latest transaction was disclosed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Quinlan Paul T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
10,000 shares@ US$7.800.0011% mcap1.2% of flowCommon StockSEC:0000907654-26-000077:0
42,000 shares@ US$12.500.0073% mcap8.4% of flowCommon StockSEC:0000907654-26-000077:1
3,630 shares@ US$106.05040.0054% mcap6.1% of flowCommon StockSEC:0000907654-26-000077:2
10,434 shares@ US$107.14020.016% mcap17.8% of flowCommon StockSEC:0000907654-26-000077:3
14,696 shares@ US$107.97350.022% mcap25.3% of flowCommon StockSEC:0000907654-26-000077:4
10,200 shares@ US$109.11310.016% mcap17.7% of flowCommon StockSEC:0000907654-26-000077:5
9,193 shares@ US$110.00390.014% mcap16.1% of flowCommon StockSEC:0000907654-26-000077:6
3,847 shares@ US$111.13780.0060% mcap6.8% of flowCommon StockSEC:0000907654-26-000077:7
733 shares@ US$41.30100.0% of flowCommon StockSEC:0000907654-26-000029:0
32,500 shares0Common StockSEC:0000907654-26-000014:0
41,824 sharesCommon StockSEC:0000950170-24-035453:0
41,824 shares@ US$7.8971.3% of flowCommon StockSEC:0001062993-24-006510:0
28,438 shares0Common StockSEC:0001062993-24-001429:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-24-000923:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-022636:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-021137:0
5,000 shares@ US$2.943.3% of flowCommon StockSEC:0001062993-23-019547:0
5,000 shares@ US$2.9414.6% of flowCommon StockSEC:0001062993-23-018278:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-016606:0
5,000 shares@ US$2.943.1% of flowCommon StockSEC:0001062993-23-014924:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-014259:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-011430:0
About Quinlan Paul T
Quinlan Paul T is a declarant and holds the role of General Counsel at CymaBay Therapeutics, Inc. and Oruka Therapeutics, Inc. He has 14 filings, and across the recent filings tracked, the period runs from 2023-05-17 to 2026-03-17, with 0 in buys and 26474 in sells; the stated transaction nature is Option exercise.